BNP Paribas Financial Markets’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $956 | Buy |
478
+7
| +1% | +$14 | ﹤0.01% | 4337 |
|
|
2025
Q1 | $1.18K | Sell |
471
-2
| -0.4% | -$5 | ﹤0.01% | 4213 |
|
|
2024
Q4 | $1.4K | Buy |
+473
| New | +$1.4K | ﹤0.01% | 4195 |
|
|
2023
Q2 | – | Sell |
-3,207
| Closed | -$12K | – | 3332 |
|
|
2023
Q1 | $12K | Buy |
3,207
+1,876
| +141% | +$7.02K | ﹤0.01% | 2912 |
|
|
2022
Q4 | $4.11K | Sell |
1,331
-978
| -42% | -$3.02K | ﹤0.01% | 3013 |
|
|
2022
Q3 | $10.5K | Buy |
2,309
+839
| +57% | +$3.83K | ﹤0.01% | 3466 |
|
|
2022
Q2 | $38.8K | Buy |
1,470
+902
| +159% | +$23.8K | ﹤0.01% | 2973 |
|
|
2022
Q1 | $21.1K | Sell |
568
-817
| -59% | -$30.4K | ﹤0.01% | 3143 |
|
|
2021
Q4 | $81K | Buy |
1,385
+218
| +19% | +$12.7K | ﹤0.01% | 3013 |
|
|
2021
Q3 | $95.9K | Buy |
1,167
+921
| +374% | +$75.7K | ﹤0.01% | 2695 |
|
|
2021
Q2 | $23.2K | Buy |
+246
| New | +$23.2K | ﹤0.01% | 2900 |
|